Klaus von Holt - Concepedia

Author

Klaus von Holt

Altria (United States)

Also Known As

Holt K, K Holt, K. Von Holt, K. von Holt, Kathi Holt, Klaus von Holt

Publications

Citations

H-Index

Concepts

All Affiliations

Altria (United States)Philip Morris International (Germany)Federal Institute for Drugs and Medical Devices University of Bonn German Center for Neurodegenerative Diseases

About

Klaus von Holt is an author at Altria (United States) specializing in medicine, tobacco control, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	333
2	Public Health	3	3	110
3	Epidemiology	3	3	110
4	Health Sciences	1	1	242
5	Geriatrics	1	1	242

Klaus von Holt

Publications

Citations

H-Index

Page 1

	Year	Citations
Association of Proton Pump Inhibitors With Risk of Dementia Willy Gomm, Klaus von Holt, Friederike Thomé, JAMA Neurology	2016	547
Risk of dementia in elderly patients with the use of proton pump inhibitors Britta Haenisch, Klaus von Holt, Birgitt Wiese, European Archives of Psychiatry and Clinical Neuroscience Alzheimer's DiseaseAgingElderly PatientsGeriatricsDementia	2014	242
Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data Willy Gomm, Klaus von Holt, Friederike Thomé, Journal of Alzheimer s Disease	2016	53
Smoking and Atherosclerotic Cardiovascular Disease: Part II: Role of Cigarette Smoking in Cardiovascular Disease Development Martin Unverdorben, Klaus von Holt, Bernhard R. Winkelmann Biomarkers in Medicine Vascular DiseaseImmunologyCardiovascular Disease DevelopmentHyperlipidemiaOxidative Stress	2009	46
Progression of atherosclerosis in the Apo E−/− model: 12-Month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet Klaus von Holt, Stefan Lebrun, Walter Stinn, Atherosclerosis Metabolic SyndromeTobacco ControlCardiovascular EpidemiologyCardiovascular DiseaseMainstream Smoke	2008	44
Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers Barbara Zedler, R. Kinser, Jan Oey, Biomarkers	2006	41
CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers Mohamadi Sarkar, Regina Stabbert, Robin D. Kinser, Toxicology and Applied Pharmacology Cannabis UseTobacco ControlTobacco UseMedicineNicotine	2006	25
Smoking and Atherosclerotic Cardiovascular Disease: Part I: Atherosclerotic Disease Process Bernhard R. Winkelmann, Klaus von Holt, Martin Unverdorben Biomarkers in Medicine Vascular DiseaseImmunologyVascular SurfaceOxidative StressInflammation	2009	20

Page 1